It was thrilling to hear President Obama call for research to find a timely cure for cancer in his address to Congress last night. Having this commitment at the highest levels of our government will only help propel the work GSK is already doing in this area.
We remain steadfast in this quest, investing time and resources to fight cancer on many fronts, notably, through cancer prevention and targeted therapies. As well, we remain committed to the cancer community, working to provide patients with access to our medicines when they cannot afford them.
Throughout his speech last night, President Obama called for bipartisan support of his initiatives, and positioned his energy, education and healthcare reform agendas as challenges for all Americans--issues to be solved by reaching across the aisle and working together. Similarly, pharmaceutical companies like GSK need to be a catalyst for healthcare reform by casting aside differences and working with important players in healthcare--policy makers, patient advocates, research organizations, payors, and the medical community--so that, collectively, we might find better treatments--and cures--for the many types of cancer plaguing us.
To build upon what Gaile said earlier today, the healthcare reform train is clearly moving, and GSK should and will be on it.
Glad to hear it, Ken. But, aside from your usual and necessary R&D, what is GSK prepared to do to help the president realize his goal of improving the health care system?